Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Cancer

Explore clinical trials studying Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

247 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Cancer trial results

Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

NCT07365241

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063 Birmingham, Alabama, United States
  • Usa Mitchell Cancer Institute /ID# 280198 Mobile, Alabama, United States
  • City Of Hope - Phoenix /ID# 281323 Goodyear, Arizona, United States
  • City of Hope National Medical Center /ID# 281322 Duarte, California, United States
View all 60 locations
View Trial Details
Recruiting

A Study of Armored CAR T Cells in People With Cancer

NCT07783477

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +19 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

NCT06780137

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of Colorado Anschutz Medical Campus ( Site 1110) Aurora, Colorado, United States
  • University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 1111) Miami, Florida, United States
  • University of Chicago ( Site 1108) Chicago, Illinois, United States
  • Dana Farber Cancer Institute ( Site 1105) Boston, Massachusetts, United States
View all 46 locations
View Trial Details
Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

NCT07155174

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Yale University School of Medicine /ID# 278181 New Haven, Connecticut, United States
  • Ocala Oncology Center /ID# 278269 Ocala, Florida, United States
  • Moffitt Cancer Center /ID# 277573 Tampa, Florida, United States
  • Fort Wayne Medical Oncology And Hematology /ID# 277336 Fort Wayne, Indiana, United States
View all 67 locations
View Trial Details
Recruiting

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

NCT07531095

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • New York University Cancer Institute New York, United States
  • Baptist Cancer Center Memphis, Tennessee, United States
  • Next Virginia Fairfax, Virginia, United States
  • Adana Sehir Egitim ve Arastirma Hastanesi Adana, Turkey (Türkiye)
View all 27 locations
View Trial Details

Related conditions